Dangerous Drug News

Side Effect Information About Dangerous Drugs and Medical Devices

Altrumedia
  • Home
  • About
  • Dangerous Drug News
  • Drugs
    • Fluoroquinolone Antibiotics
    • Pradaxa
    • Proton Pump Inhibitors
    • Risperdal
    • Talcum Powder
    • Taxotere
    • Xarelto
    • Zofran
  • Medical Devices
    • Essure
    • IVC Filters
    • Power Morcellators
    • Transvaginal Mesh
  • Free Case Evaluation

Power Morcellators

12902914_m

Power morcellators are used in some hysterectomies and myomectomies. Myomectomy is surgery to remove fibroids. Hysterectomy and myomectomy with power morcellation are minimally invasive surgeries, but the U.S. Food and Drug Administration (FDA) now recommends against using the device in these surgeries because of the risk of spreading unsuspected cancer.

What is Power Morcellation?

Laparoscopic power morcellation is a minimally invasive surgical procedure used to remove the uterus or fibroids. A small incision is made, usually in the naval. The morcellator is a small bladed power tool which is inserted through the incision. The morcellator blades spin, cutting the uterus or fibroids into tiny pieces that can be removed by suction through a narrow tube.

The advantage of power morcellation is that it is allows for a minimally invasive procedure. The incision is small, so there is less trauma to the tissues, and recovery is faster and easier than with traditional surgery.

The Risks of Power Morcellation

After power morcellation, most of the cut up tissue is removed. However, as the blades spin and chop during power morcellation, tiny pieces of the minced tissue are spread throughout the abdomen and pelvis and all of them cannot be removed. If the tissue is healthy this is harmless, but if cancer is present, the cancer cells are spread throughout the abdomen and pelvis.

Localized cancer is easier to treat and treatment is likely to be successful. Cancer that is spread out cannot easily be removed or targeted for treatment. The chance of long-term survival is much lower, and the cancer may not be treatable at all.

When cancer progresses naturally it usually takes time to spread, meaning that there are opportunities to catch the cancer and treat it in its early stages while it is still localized. When the cancer is spread artificially, the first detection may not occur until the cancer is in late stages and no longer treatable.

FDA Safety Warning

On April 17, 2014, the FDA issued a safety warning discouraging the use of laparoscopic power morcellation during hysterectomy and myomectomy for treatment of uterine fibroids.

According to the FDA, “it is estimated that 1 in 350 women undergoing hysterectomy or myomectomy for the treatment of fibroids is found to have an unsuspected uterine sarcoma, a type of uterine cancer that includes leiomyosarcoma.” The FDA also says that “there is no reliable method for predicting whether a woman with fibroids may have a uterine sarcoma.”

If you have questions about power morcellators or if you believe you or a loved one contracted a more aggressive form of cancer as a result of the morcellation technique used, please contact us for a free case evaluation.  We will help you find answers to your questions. If you need legal assistance we can help you find an attorney who represents people harmed by power morcellators.

Share this:

  • Facebook
  • LinkedIn
  • Twitter

RSS FDA Med Watch

  • 2023 Safety Communications
  • Evaluation of Safety Concerns with Certain Dental Devices Used on Adults – FDA Safety Communication
  • Jarman’s Midwest Cleaning Systems, Inc. Issues Voluntary Nationwide Recall of Alcohol Antiseptic 80% Topical Solution Hand Sanitizer Non-sterile Solution and Isopropyl Alcohol Antiseptic 75% Topical Solution Hand Sanitizer Non-sterile Solution Due to Presence of Methanol
  • Risks with Exactech Joint Replacement Devices with Defective Packaging – FDA Safety Communication
  • Ascend Laboratories LLC. Issues Voluntary Nationwide Recall of Dabigatran Etexilate Capsules, USP 75 mg and 150 mg, Due to the Detection of N-Nitroso-dabigatran (NDAB) Impurity
  • UPDATE: Reports of Squamous Cell Carcinoma (SCC) in the Capsule Around Breast Implants - FDA Safety Communication
  • 2023 Medical Device Recalls

Recent Headlines

Diabetic Man Testing Blood Levels

Type 2 Diabetes Drugs Pose Numerous Health Risks

The hits just keep coming for Johnson & Johnson, and now its … [Read More...]

PPIs Side Effects

PPI Heartburn and Ulcer Medications May Cause Stomach Cancer

Proton pump inhibitors (PPIs) are used to treat heartburn, … [Read More...]

Johnson & Johnson Loses Second Major Talcum Powder Case

In its second trial loss in less than 3 months, Johnson & … [Read More...]

Find an Attorney

RSS US Recall News

  • Belviq Withdrawn Due to Cancer Risk
  • Common Heartburn Medication may lead to bladder, stomach, and other cancers. Zantac Lawsuits begin.
  • J&J Settles Talc Mesothelioma Settlement

RSS Lawsuits and Settlements

  • Possible Lawsuit: CPAP Lung Cancer Lawsuit News and Legal Information
  • Possible Lawsuit: Birth Injury and Birth Defect Lawsuit News and Legal Information
  • Possible Lawsuit: Wyoming Medical Malpractice Lawsuit News & Legal Information

RSS Mass Tort News

RSS Health Industry

  • BREAKING: Gwyneth Paltrow Cleared In $3M Ski Crash Trial
  • Ex-CEO Whistleblower Nets $12M In Hospital's $69M FCA Deal
  • BREAKING: Trump Charged In Sealed NY Indictment

ABOUT US

DRUG INFO

DEVICES

CASE REVIEW

NEWS

Copyright © 2023 DangerousDrugNews.com · Site Map - Website Development by Altrumedia · Log in